Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper

María Dolores García-Cosío Carmena1, Marta Farrero2, María Teresa Blasco Peiró3

  • 1Cardiology Department, Hospital Universitario 12 de Octubre, Imas12, CIBERCV, Madrid, Spain.

Transplantation
|February 10, 2025
PubMed

Insights

Managing kidney disease in heart transplant recipients is complex. This expert consensus provides guidance on identifying, managing, and considering kidney transplantation for these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Transplantation Medicine

Background:

  • Kidney disease is a frequent complication in heart transplant recipients.
  • Management is challenging due to pre-existing conditions, perioperative factors, immunosuppression, and cardiovascular issues.

Purpose of the Study:

  • To establish expert consensus on managing chronic kidney disease (CKD) in heart transplant recipients.
  • To provide guidance where clinical evidence is limited.

Main Methods:

  • A panel of Spanish cardiologists and nephrologists reviewed existing evidence.
  • Consensus statements were developed using a 2-round Delphi methodology.

Main Results:

  • Developed consensus statements on key aspects of CKD management.
  • Addressed identification, management, and kidney transplantation indications.

Conclusions:

  • The consensus provides expert guidance for a complex clinical scenario.
  • Aims to improve care for heart transplant recipients with kidney disease.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374